World's Best Scientists 2026 revealed!
Caterina Giannini

Caterina Giannini

D-Index & Metrics

Medicine

D-Index
115
Citations
50992
World Ranking
4523
National Ranking
2460

Caterina Giannini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Caterina Giannini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 559 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Caterina Giannini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Caterina Giannini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Caterina Giannini is affiliated with the Mayo Clinic in the United States. Their research contributions span multiple aspects of medicine and biochemistry, genetics, and molecular biology, with a strong focus on neurological conditions and cancer biology. The scientist's work is widely published and includes notable papers addressing tumor classification, grading criteria, and molecular pathways.

Their recent publications include:

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading, 2020, Brain Pathology
  • cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas, 2020, Acta Neuropathologica
  • ABP1-TMK auxin perception for global phosphorylation and auxin canalization, 2022, Nature
  • Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis, 2020, JAMA Neurology
  • Failure of human rhombic lip differentiation underlies medulloblastoma formation, 2022, Nature

Caterina Giannini frequently collaborates with other researchers, including Robert B. Jenkins, Rachael A. Vaubel, Aditya Raghunathan, Kenneth Aldape, and Evanthia Galanis. These collaborations have contributed to various topics within the neurosciences and oncology fields.

The scientist regularly publishes in venues focused on neuropathology and neuro-oncology. Key publication venues include:

  • Neuro-Oncology (33 publications)
  • Journal of Neuropathology & Experimental Neurology (11 publications)
  • Brain Pathology (10 publications)
  • Acta Neuropathologica (9 publications)
  • Neuro-Oncology Advances (9 publications)

Giannini's main fields of study encompass:

  • Medicine with 333 publications
  • Biochemistry, Genetics and Molecular Biology with 97 publications

Within these broad fields, their subfields of study include:

  • Genetics (90 publications)
  • Molecular Biology (58 publications)
  • Neurology (54 publications)
  • Pulmonary and Respiratory Medicine (40 publications)
  • Epidemiology (31 publications)

The topics of Caterina Giannini's research are diverse but center mainly on neuroscience and oncology issues. The primary topics covered are:

  • Glioma Diagnosis and Treatment (162 publications)
  • Meningioma and schwannoma management (52 publications)
  • Neurofibromatosis and Schwannoma Cases (36 publications)
  • Pituitary Gland Disorders and Treatments (32 publications)
  • Neuroblastoma Research and Treatments (28 publications)
  • Brain Metastases and Treatment (26 publications)
  • Chromatin Remodeling and Cancer (26 publications)

Best Publications

  • Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

    Daniel J. Brat;Roel G.W. Verhaak;Kenneth D. Aldape;W. K.Alfred Yung

  • Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.

    Michele Ceccarelli;Floris P Barthel;Tathiane M Malta;Thais S Sabedot

  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

    Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh

  • Inflammatory Cortical Demyelination in Early Multiple Sclerosis

    Claudia F. Lucchinetti;Bogdan F.G. Popescu;Reem F. Bunyan;Natalia M. Moll

  • Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Florence M.G. Cavalli;Marc Remke;Marc Remke;Marc Remke;Ladislav Rampasek;John Peacock

  • Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

    Paul D. Brown;Paul D. Brown;Karla V. Ballman;Karla V. Ballman;Jane H. Cerhan;S. Keith Anderson

  • A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

    Robert B. Jenkins;Hilary Blair;Karla V. Ballman;Caterina Giannini

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • Primary central nervous system vasculitis: analysis of 101 patients.

    Carlo Salvarani;Robert D. Brown;Kenneth T. Calamia;Teresa J. H. Christianson

  • Pathology of Peripheral Nerve Sheath Tumors: Diagnostic Overview and Update on Selected Diagnostic Problems

    Fausto J. Rodriguez;Andrew L. Folpe;Caterina Giannini;Arie Perry

  • Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility

    Margaret Wrensch;Robert B. Jenkins;Jeffrey S. Chang;Ru Fang Yeh

  • Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

    Jann N Sarkaria;Leland S Hu;Ian F Parney;Deanna H Pafundi

  • Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

    C. F. Lucchinetti;R. H. Gavrilova;I. Metz;J. E. Parisi

  • Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH

    J. Gregory Cairncross;Meihua Wang;Robert B. Jenkins;Edward G. Shaw

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.

    David N. Louis;Pieter Wesseling;Kenneth Aldape;Daniel J. Brat

  • Pleomorphic xanthoastrocytoma: What do we really know about it

    Caterina Giannini;Bernd W. Scheithauer;Peter C. Burger;Daniel J. Brat

  • The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

    Karla V. Ballman;Jan C. Buckner;Paul D. Brown;Caterina Giannini

  • cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.

    Daniel J. Brat;Kenneth Aldape;Howard Colman;Dominique Figrarella-Branger

  • Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

    Evanthia Galanis;Kurt A. Jaeckle;Matthew J. Maurer;Joel M. Reid

  • Pilocytic astrocytoma: pathology, molecular mechanisms and markers

    V. Peter Collins;David T. W. Jones;Caterina Giannini

Frequent Co-Authors

Jan C. Buckner
Jan C. Buckner Mayo Clinic
Jann N. Sarkaria
Jann N. Sarkaria Mayo Clinic
Paul D. Brown
Paul D. Brown Mayo Clinic
Evanthia Galanis
Evanthia Galanis Mayo Clinic
Karla V. Ballman
Karla V. Ballman Cornell University
Gene G. Hunder
Gene G. Hunder Mayo Clinic
Carlo Salvarani
Carlo Salvarani University of Modena and Reggio Emilia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn't always mean becoming a doctor. There are multiple online degree options and career pathways that support the broader healthcare sector, often with quicker or more affordable routes. For those looking to enter patient care quickly, fast track medical programs like accelerated Licensed Practical Nurse (LPN) tracks offer a fast entry into nursing roles.

Advanced practice and specialty nursing remain in high demand. If you already hold a master's degree in nursing, the fastest post master's pmhnp online programs allow you to quickly become a Psychiatric Mental Health Nurse Practitioner (PMHNP), opening doors to mental health careers.

Leadership or administrative roles in healthcare are also accessible through online degrees. Consider a healthcare administration degree online for foundational skills in managing clinics, hospitals, or health systems. For advanced opportunities, the most affordable mha programs offer a flexible way to earn a Master’s in Healthcare Administration.

Best Scientists Citing Caterina Giannini

Trending Scientists

Recently Published Articles